Key facts
- This page summarizes Douglas J. Williamson's Form 4 filing for AVADEL PHARMACEUTICALS PLC (AVDL).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 16 Feb 2022, 15:40.
Douglas J. Williamson - 14 Feb 2022 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- AVDL
- Reported as of
- 14 Feb 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Feb 2022, 15:40:17 UTC
- Next SEC filing
- 13 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jerad G. Seurer, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Douglas J. Williamson filed Form 4 for AVADEL PHARMACEUTICALS PLC (AVDL) on 16 Feb 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AVDL
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +275,000
- Change %
- Price
- $0.000000
- Shares after
- 275,000
- Date
- 14 Feb 2022
- Ownership
- Direct
- Underlying class
- ADSs
- Underlying amount
- 275,000
- Exercise price
- $6.60
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Options become exercisable as to 68,750 ADSs on each of the first four anniversaries after the 2/14/2022 grant date.
Footnote F2
The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.